Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Forticell Bioscience Inc.

Latest From Forticell Bioscience Inc.

Start-Ups Move Stem Cell Products Forward On Long Path To Market

The dream of turning stem cell research into mainstream clinical therapies is making significant progress, as a large number of cell-based clinical studies are currently underway - some 2,700 stem cell clinical trials registered with www.clinicaltrials.gov between February 2000 and June 2010. While several companies have launched stem cell products onto the market, it’s the number of products in the pipeline that is starting to capture the attention of observers – including investors – who believe activity in current clinical trials is a telling sign of where the industry is headed.

BioPharmaceutical Medical Device

ZymoGenetics' Biotech Disconnect

It's logical to think that synthetic thrombin is safer than bovine- or plasma-derived equivalents. But ZymoGenetics is finding out that it's not an easy sell, especially to Wall Street.

BioPharmaceutical Medical Device

ZymoGenetics Experiences a Biotech Disconnect

It's logical to think that synthetic thrombin is safer than bovine- or plasma-derived equivalents. But ZymoGenetics is finding out it's not an easy sell, especially to Wall Street.

BioPharmaceutical Medical Device

Salve for the Wound Care Market

Wound care, once known as an investment graveyard, is changing. An advanced wound care market that once focused high-end technology on the small and difficult market of burns has now recognized an opportunity in chronic wounds, an enormous and growing market driven by the demographics of aging, and that segment has recently witnessed a dramatic success story. In 2004, the most successful medical device IPO was that of wound care company Kinetic Concepts.

Medical Device Platform Technologies
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Biomaterials
  • Other Names / Subsidiaries
    • Ortec International, Inc.
    • Orcel LLC
    • Hapto Biotech (Israel) Ltd.
UsernamePublicRestriction

Register